Cinobufotalin
Cinobufotalin Basic information
- Product Name:
- Cinobufotalin
- Synonyms:
-
- cinobufotalin venom toad
- Cinobufotalin std.
- 5BETA,20[22]-BUFADIENOLIDE-14,15BETA-EPOXY-3BETA,5ALPHA,16BETA-TRIOL 16-ACETATE
- 14,15-beta-epoxy-3-beta,5,16-beta-trihydroxy-22-dienolid16-5-beta-bufa-2
- CINOBUFOTALIN(RG)
- 14,15b-Epoxy-3b,5a,16b-trihydroxy-5b,20(22)-bufadienolide 16-acetate
- 5β,20(22)-Bufadienolide-14,15β-epoxy-3β,5α,16β-triol 16-acetate, 14,15β-Epoxy-3β,5α,16β-trihydroxy-5β,20(22)-bufadienolide 16-acetate
- 14,15-Epoxy-14H-cyclopenta[a]phenanthrene, bufa-20,22-dienolide deriv.
- CAS:
- 1108-68-5
- MF:
- C26H34O7
- MW:
- 458.54
- Mol File:
- 1108-68-5.mol
Cinobufotalin Chemical Properties
- Melting point:
- 259-262°
- alpha
- D20 +11°
- Boiling point:
- 627.3±55.0 °C(Predicted)
- Density
- 1.34±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- solubility
- DMF: 10 mg/ml; DMF:PBS (pH 7.2) (1:1): 0.5 mg/ml; DMSO: 5 mg/ml; Ethanol: 5 mg/ml
- pka
- 14.67±0.70(Predicted)
- form
- White to off-white solid.
- color
- White to off-white
- CAS DataBase Reference
- 1108-68-5
Safety Information
- Hazard Codes
- T+
- Risk Statements
- 26/27/28
- Safety Statements
- 22-36/37/39-45
- RIDADR
- UN 2811 6.1/PG 1
- WGK Germany
- 3
- RTECS
- EI2991000
- HazardClass
- 6.1(a)
- PackingGroup
- II
- Toxicity
- cat,LD50,intravenous,200ug/kg (0.2mg/kg),"Die Herzwirksamen Glykoside," Baumgarten, G., and W. Forster, Leipzig, Ger. Dem. Rep., VEB Georg Thieme, 1963Vol. -, Pg. 189, 1963.
MSDS
- Language:English Provider:14,15b-Epoxy-3b,5a,16b-trihydroxy-5b,20(22)-bufadienolide 16-acetate
- Language:English Provider:SigmaAldrich
Cinobufotalin Usage And Synthesis
Description
Cinobufacin is an indole-type total alkaloid extracted from the dried toad skin of Chinese toad, which has the functions of clearing away heat and detoxifying, reducing swelling and pain, promoting blood circulation and removing blood stasis, softening and dispelling knots.
Application
Cinobufacin can be used for a variety of middle and advanced tumors (lung cancer, breast cancer, cervical cancer, digestive system tumors such as primary liver cancer, gastric cancer, colon cancer, etc.), chronic hepatitis B, especially for chronic hepatitis B virus carriers. Especially prominent.
Side effects
For individual patients, if the dosage is too large or the interval between two administrations is less than 6 to 8 hours, chills and fever may occur about 30 minutes after administration; a small number of patients have local irritation or phlebitis after long-term intravenous infusion, which will slow down the infusion rate. Very few patients may also appear urticaria, dermatitis and so on.
CinobufotalinSupplier
- Tel
- 025-58862853 18915922038
- sales@endesachem.com
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- 0086-21-58956006
- Tel
- 0411-62910999 13889544652
- meilunui@163.com
- Tel
- +86-028-82633397 18982077548
- cwb1@biopurify.cn
Cinobufotalin(1108-68-5)Related Product Information
- Ethyl acetate
- Sodium acetate
- Vinyl acetate
- Methyl acetate
- Glatiramer acetate
- Butyl acetate
- Potassium Acetate
- Tocopheryl acetate
- ACETATE
- bufoin injection
- ALPHA-PYRONE
- 1,2-EPOXYTETRADECANE
- (R)-(+)-1,2-Epoxybutane
- 1,2-Epoxydodecane
- TERPIN MONOHYDRATE
- 2,3-EPOXY-2-METHYLBUTANE
- CIS-1,2-CYCLOPENTANEDIOL
- (R)-(+)-Glycidol